The expulsion of lipophilic drugs from the cores of solid lipid microspheres in diluted suspensions and in concentrates

International Journal of Pharmaceutics

Volumn 310, Issue 1-2, 2006, Pages 64-71

  Pietkiewicz, Justyna ^a   Sznitowska, Malgorzata ^a   Placzek, Marcin ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Bupivacaine; Bupivacaine stearate; Concentrated lipospheres; Expulsion; Incorporation; Indomethacin; Lipospheres

Indexed keywords

BUPIVACAINE; BUPIVACAINE STEARATE; GLYCEROL PALMITOSTEARATE; INDOMETACIN; MIGLYOL; POLYMER; SOLID LIPID NANOPARTICLE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ARTICLE; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG SOLUBILITY; DRUG SYNTHESIS; EMULSION; LIPID COMPOSITION; LIPOPHILICITY; PRECIPITATION; PRIORITY JOURNAL; SUSPENSION;

ANESTHETICS, LOCAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BUPIVACAINE; CRYSTALLIZATION; DRUG CARRIERS; GLYCERIDES; INDOMETHACIN; MICROSPHERES; PARTICLE SIZE; SOLUBILITY; SUSPENSIONS; WATER;

EID: 33344476293     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2005.11.038     Document Type: Article

References (23)

1. P. Ahlin, J. Kristl, M. Sentjurc, J. Strancar, and S. Pecar Influence of spin probe structure on its distribution in SLN dispersions Int. J. Pharm. 196 2000 241 244
2. P. Ahlin, J. Kristl, S. Pecar, J. Strancar, and M. Sentjurc The effect of lipophilicity of spin-labeled compounds on their distribution in solid lipid nanoparticle dispersions studied by electron paramagnetic resonance J. Pharm. Sci. 92 2003 58 66
3. H. Bunjes, K. Westesen, and M.H. Koch Crystallization tendency and polymorphic transitions in triglyceride nanoparticles Int. J. Pharm. 129 1996 159 173
4. H. Bunjes, M. Drechsler, M.H.J. Koch, and K. Westesen Incorporation of the model drug ubidecarenone into solid lipid nanoparticles Pharm. Res. 18 2001 287 293
5. H. Bunjes, M.H. Koch, and K. Westesen Influence of emulsifiers on the crystallization of solid lipid nanoparticles J. Pharm. Sci. 92 2003 1509 1520
6. D.B. Chen, T. Yang, W.L. Lu, and Q. Zhang In vitro and in vivo study of two types of long-circulating solid lipid nanoparticles containing paclitaxel Chem. Pharm. Bull. 49 2001 1444 1447
7. M.R. Gasco Solid lipid nanoparticle for drug delivery Pharm. Technol. 13 2001 33 42
8. H.K. Frederiksen, H.G. Kristensen, and M. Pedersen Solid lipid microparticle formulations of the pyrethroid gamma-cyhalothrin - incompatibility of the lipid and the pyrethroid and biological properties of the formulation J. Contr. Release 86 2003 243 252
9. C. Freitas, and R.H. Müller Correlation between long-term stability of solid lipid nanoparticles (SLN) and crystallinity of the lipid phase Eur. J. Pharm. Biopharm. 47 1999 125 132
10. D.Z. Hou, C.S. Xie, K.J. Huang, and C.H. Zhu The production and characteristics of solid lipid nanoparticles (SLNs) Biomaterials 24 2003 1781 1785
11. F.Q. Hu, M.Z. Wu, H. Yuan, and H.H. Zhang A novel preparation of solid lipid nanoparticles with cyclosporin A for prolonged release Pharmazie 59 2004 683 685
12. V. Jenning, A.F. Thünemann, and S.H. Gohla Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids Int. J. Pharm. 199 2000 167 177
13. K. Jores, W. Mehnert, and K. Mäder Physicochemical investigations on solid lipid nanoparticles and on oil-loaded solid lipid nanoparticles: a nuclear magnetic resonance and electron spin resonance study Pharm. Res. 20 2003 1274 1283
14. K. Jores, W. Mehnert, M. Drechsler, H. Bunjes, C. Johann, and K. Mäder Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy J. Contr. Release 95 2004 217 227
15. D.A. Masters, and A.J. Domb Liposphere local anesthetic timed-release for perineural site application Pharm. Res. 15 1998 1038 1045
16. A. Mühlen, C. Schwarz, and W. Mehnert Solid lipid nanoparticles (SLN) for controlled drug delivery - drug release and release mechanism Eur. J. Pharm. Biopharm. 45 1998 149 155
17. R.H. Müller, K. Mäder, and S. Gohla Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art Eur. J. Pharm. Biopharm. 50 2000 161 177
18. R.H. Müller, M. Radtke, and S.A. Wissing Nanostructured lipid matrices for improved microencapsulation of drugs Int. J. Pharm. 242 2002 121 128
19. J. Pietkiewicz, and M. Sznitowska The choice of lipids and surfactants for injectable extravenous microspheres Pharmazie 59 2004 325 326
20. S. Toongsuwan, L.C. Li, B.K. Erickson, and H.C. Chang Formulation and characterization of bupivacaine lipospheres Int. J. Pharm. 280 2004 57 65
21. K. Westesen, H. Bunjes, and M.H.J. Koch Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential J. Contr. Release 48 1997 223 236
22. S.A. Wissing, R.H. Müller, L. Manthel, and C. Mayer Structural characterization of Q10-loaded solid lipid nanoparticles by NMR spectroscopy Pharm. Res. 21 2004 400 405
23. S.A. Wissing, O. Kayser, and R.H. Müller Solid lipid nanoparticles for parenteral drug delivery Adv. Drug Deliv. Rev. 56 2004 1257 1272